General details

PD-L1 precision medicine has rapidly expanded in the last few years however, with a range of PD-L1/PD-1 precision medicine therapies existing alongside several commercially available assays and standalone antibodies. As a result, recommendations regarding scoring algorithms and clinical cut-offs can vary depending on the assay-indication combination and may result in the incorrect test being performed and the patient receiving a result that is incorrectly matched to the therapy being considered.

Diaceutics has partnered with internationally established healthcare service partner Targos to bring you this opportunity to receive PD-L1 agnostic training. This virtual group training session will be delivered over 2 days (4 hours each day).

Why join the collaboration:

• Receive Diaceutics sponsorship to participate in a virtual training program that will help you develop knowledge of the scoring of PD-L1 (TPS/CPS/IC) in HNSCC, UC, GC and TNBC
• Gain a deeper understanding regarding the complexities associated with quality assurance (internal and external) as well as implementation and validation of PD-L1 testing in the laboratory
• Participate in an interactive digital microscope session that reviews example cases for each indication and scoring algorithms
• Use an online platform (PathXL) to perform self-assessment with example images

Requirements

To be eligible to participate in this collaboration please ensure that:
1. Lab profile information reflects:
a. Available in-house IHC auto-stainer details
b. External Quality Assurance (EQA) schemes or proficiency testing (PT) programs that are being subscribed to for PD-L1 testing

2. Your lab assay details reflect:
a. Current PD-L1 testing methods and turnaround times
b. Scoring algorithms and reporting formats
c. Q1, Q2 and Q3 2020 PD-L1 volumes for indications covered within your service
*Please note, where multiple assays are available in-house, these must be logged as individual assays per antibody

Documentation

Download